Tony Ye, Ph.D. - Related publications

2013-2018 Psychology University of Arizona, Tucson, AZ 
Cognitive Neuroscience, Electrophysiology, Decision-Making, Animal Models, Parkinson's disease
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Moënne-Loccoz C, Astudillo-Valenzuela C, Skovgård K, Salazar-Reyes CA, Barrientos SA, García-Núñez XP, Cenci MA, Petersson P, Fuentes-Flores RA. Cortico-Striatal Oscillations Are Correlated to Motor Activity Levels in Both Physiological and Parkinsonian Conditions. Frontiers in Systems Neuroscience. 14: 56. PMID 32903888 DOI: 10.3389/fnsys.2020.00056   
2020 Singh A, Papa SM. Striatal oscillations in parkinsonian non-human primates. Neuroscience. PMID 32905842 DOI: 10.1016/j.neuroscience.2020.09.004   
2020 Calabrese V, Di Maio A, Marino G, Cardinale A, Natale G, De Rosa A, Campanelli F, Mancini M, Napolitano F, Avallone L, Calabresi P, Usiello A, Ghiglieri V, Picconi B. Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia. Frontiers in Aging Neuroscience. 12: 230. PMID 32848709 DOI: 10.3389/fnagi.2020.00230   
2020 Song MK, Lee JH, Kim J, Kim JH, Hwang S, Kim YS, Kim YJ. Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease model. Neuroscience Letters. 135425. PMID 33075422 DOI: 10.1016/j.neulet.2020.135425   
2020 Saini N, Akhtar A, Chauhan M, Dhingra N, Pilkhwal Sah S. Protective effect of Indole-3-carbinol, an NF-κB inhibitor in experimental paradigm of Parkinson's disease: In silico and in vivo studies. Brain, Behavior, and Immunity. PMID 32800927 DOI: 10.1016/j.bbi.2020.08.001   
2020 Behl T, Kaur G, Bungau S, Jhanji R, Kumar A, Mehta V, Zengin G, Brata R, Hassan SSU, Fratila O. Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson's Disease: A Perspective on Associated Therapeutic Interventions. International Journal of Molecular Sciences. 21. PMID 32872273 DOI: 10.3390/ijms21176235   
2020 Biolchi AM, de Oliveira DGR, Amaral HO, Campos GAA, Gonçalves JC, de Souza ACB, Lima MR, Silva LP, Mortari MR. Fraternine, a Novel Wasp Peptide, Protects against Motor Impairments in 6-OHDA Model of Parkinsonism. Toxins. 12. PMID 32867207 DOI: 10.3390/toxins12090550   
2020 Beaudry F, Huot P. The MPTP-lesioned marmoset model of Parkinson's disease: proposed efficacy thresholds that may potentially predict successful clinical trial results. Journal of Neural Transmission (Vienna, Austria : 1996). 127: 1343-1358. PMID 32860561 DOI: 10.1007/s00702-020-02247-2   
2020 Thompson AM, Farmer K, Rowe EK, Hayley SP. Erythropoietin modulates antioxidant signalling. Molecular and Cellular Neurosciences. 103554. PMID 32971229 DOI: 10.1016/j.mcn.2020.103554   
2020 Saleem U, Chauhdary Z, Raza Z, Shah S, Rahman MU, Zaib P, Ahmad B. Anti-Parkinson's Activity of via Modulation of AChE, α-Synuclein, TNF-α, and IL-1β. Acs Omega. 5: 25216-25227. PMID 33043200 DOI: 10.1021/acsomega.0c03375   
2020 Olanow CW, Calabresi P, Obeso JA. Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32816321 DOI: 10.1002/mds.28215   
2020 Wang Y, Wei N, Li X. Preclinical Evidence and Possible Mechanisms of Baicalein for Rats and Mice With Parkinson's Disease: A Systematic Review and Meta-Analysis. Frontiers in Aging Neuroscience. 12: 277. PMID 33101006 DOI: 10.3389/fnagi.2020.00277   
2020 Fabbri M, Perez-Lloret S, Rascol O. Therapeutic strategies for Parkinson's disease: promising agents in early clinical development. Expert Opinion On Investigational Drugs. 1-19. PMID 32853086 DOI: 10.1080/13543784.2020.1814252   
2020 Cankara FN, Günaydın C, Bilge SS, Özmen Ö, Kortholt A. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta. Neuroscience Letters. 738: 135308. PMID 32932183 DOI: 10.1016/j.neulet.2020.135308   
2020 Yamamoto T, Sakakibara R, Uchiyama T, Kuwabara S. Subthalamic Stimulation Inhibits Bladder Contraction by Modulating the Local Field Potential and Catecholamine Level of the Medial Prefrontal Cortex. Frontiers in Neuroscience. 14: 917. PMID 33013304 DOI: 10.3389/fnins.2020.00917   
2020 Leuk JSP, Low LLN, Teo WP. An Overview of Acoustic-Based Interventions to Improve Motor Symptoms in Parkinson's Disease. Frontiers in Aging Neuroscience. 12: 243. PMID 32922283 DOI: 10.3389/fnagi.2020.00243   
2020 Bayo-Olugbami A, Nafiu AB, Amin A, Ogundele OM, Lee CC, Owoyele BV. Vitamin D attenuated 6-OHDA-induced behavioural deficits, dopamine dysmetabolism, oxidative stress, and neuro-inflammation in mice. Nutritional Neuroscience. 1-12. PMID 32912107 DOI: 10.1080/1028415X.2020.1815331   
2020 Bittencourt A, Brum PO, Ribeiro CT, Gasparotto J, Bortolin RC, de Vargas AR, Heimfarth L, de Almeida RF, Moreira JCF, de Oliveira J, Gelain DP. High fat diet-induced obesity causes a reduction in brain tyrosine hydroxylase levels and non-motor features in rats through metabolic dysfunction, neuroinflammation and oxidative stress. Nutritional Neuroscience. 1-15. PMID 33078695 DOI: 10.1080/1028415X.2020.1831261   
2020 Abbasi MH, Esmaeili S, Habibi SA, Shahidi GA. Dilemma in Parkinson's Treatment; Levodopa Monotherapy May be the Best Choice. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 79: 219-223. PMID 33070900 DOI: 10.1016/j.jocn.2020.06.024   
2020 Weaver KE, Caldwell DJ, Cronin JA, Kuo CH, Kogan M, Houston B, Sanchez V, Martinez V, Ojemann JG, Rane S, Ko AL. Concurrent Deep Brain Stimulation Reduces the Direct Cortical Stimulation Necessary for Motor Output. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32914888 DOI: 10.1002/mds.28255   
2020 Samotus O, Lee J, Jog M. Standardized algorithm for muscle selection and dosing of botulinum toxin for Parkinson tremor using kinematic analysis. Therapeutic Advances in Neurological Disorders. 13: 1756286420954083. PMID 33014139 DOI: 10.1177/1756286420954083   
2020 Sun Y, Lu XJ, Fu X, Zhang Y, Zhan Y, Liu J, Zhao L, Xia CL. Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease. Molecular and Cellular Biochemistry. PMID 33070275 DOI: 10.1007/s11010-020-03931-3   
2020 Aguirre-Vidal Y, Rodríguez-Ramos C, Mendieta L, Romero-Sánchez HA, Garza-Mouriño G, Benítez-Díaz Mirón MI, Castellanos-Páez ME, Pérez-Ramos J, Godínez-Chaparro B. Synergistic antiallodynic and antihyperalgesic interaction between L-DOPA and celecoxib in parkinsonian rats is mediated by NO-cGMP-ATP-sensitive K channel. European Journal of Pharmacology. 889: 173537. PMID 32971091 DOI: 10.1016/j.ejphar.2020.173537   
2020 Schmidt SL, Brocker DT, Swan BD, Turner DA, Grill WM. Evoked potentials reveal neural circuits engaged by human deep brain stimulation. Brain Stimulation. 13: 1706-1718. PMID 33035726 DOI: 10.1016/j.brs.2020.09.028   
2020 Blosser JA, Podolsky E, Lee D. L-DOPA-Induced Dyskinesia in a Genetic Drosophila Model of Parkinson's Disease. Experimental Neurobiology. 29: 273-284. PMID 32921640 DOI: 10.5607/en20028   
2020 Altwal F, Moon C, West AR, Steiner H. The Multimodal Serotonergic Agent Vilazodone Inhibits L-DOPA-Induced Gene Regulation in Striatal Projection Neurons and Associated Dyskinesia in an Animal Model of Parkinson's Disease. Cells. 9. PMID 33050305 DOI: 10.3390/cells9102265   
2020 Ito H, Yokoi D, Kobayashi R, Okada H, Kajita Y, Okuda S. The relationships between three-axis accelerometer measures of physical activity and motor symptoms in patients with Parkinson's disease: a single-center pilot study. Bmc Neurology. 20: 340. PMID 32912171 DOI: 10.1186/s12883-020-01896-w   
2020 Zhao F, Tian H, Chinnathambi A, Alharbi SA, Yang H. Neuroprotective effect of rhaponticin against Parkinson disease: Insights from in vitro BV-2 model and in vivo MPTP-induced mice model. Journal of Biochemical and Molecular Toxicology. e22631. PMID 32926752 DOI: 10.1002/jbt.22631   
2020 Andrews JC, Roy FD, Ba F, Sankar T. Intraoperative changes in the H-reflex pathway during Deep Brain Stimulation surgery for Parkinson's Disease: a potential biomarker for optimal electrode placement. Brain Stimulation. PMID 33035725 DOI: 10.1016/j.brs.2020.09.024   
2020 Dafsari HS, Gabriela Dos Santos Ghilardi M, Visser-Vandewalle V, Rizos A, Ashkan K, Silverdale M, Evans J, Martinez RCR, Cury RG, Jost ST, Barbe MT, Fink GR, Antonini A, Ray-Chaudhuri K, Martinez-Martin P, ... , et al. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease. Brain Stimulation. PMID 33038595 DOI: 10.1016/j.brs.2020.09.019   
2020 Li H, Feng Y, Chen Z, Jiang X, Zhou Z, Yuan J, Li F, Zhang Y, Huang X, Fan S, Wu X, Huang C. Pepper component 7-ethoxy-4-methylcoumarin, a novel dopamine D2 receptor agonist, ameliorates experimental Parkinson's disease in mice and Caenorhabditis elegans. Pharmacological Research. 105220. PMID 33007422 DOI: 10.1016/j.phrs.2020.105220   
2020 Parambi DGT, Saleem U, Shah MA, Anwar F, Ahmad B, Manzar A, Itzaz A, Harilal S, Uddin MS, Kim H, Mathew B. Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson's Disease. Neurochemical Research. PMID 32939670 DOI: 10.1007/s11064-020-03130-y   
2020 Xiong S, Liu W, Zhou Y, Mo Y, Liu Y, Chen X, Pan H, Yuan D, Wang Q, Chen T. Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation. Asian Journal of Pharmaceutical Sciences. 15: 518-528. PMID 32952674 DOI: 10.1016/j.ajps.2019.04.003   
2020 Haider M, Salman M, Kaushik P, Bharadwaj N, Aggarwal N, Tabassum H, Parvez S. Chrysin ameliorates 3 nitropropinoic acid induced neurotoxicity targeting behavioural, biochemical and histological alterations. The International Journal of Neuroscience. 1-11. PMID 32901525 DOI: 10.1080/00207454.2020.1821677   
2020 de Almeida GRL, Szczepanik JC, Selhorst I, Schmitz AE, Dos Santos B, Cunha MP, Heinrich IA, de Paula GC, De Bem AF, Leal RB, Dafre AL. Methylglyoxal-Mediated Dopamine Depletion, Working Memory Deficit, and Depression-Like Behavior Are Prevented by a Dopamine/Noradrenaline Reuptake Inhibitor. Molecular Neurobiology. PMID 33011857 DOI: 10.1007/s12035-020-02146-3   
2020 Antunes MS, Ladd FVL, Ladd AABL, Moreira AL, Boeira SP, Cattelan Souza L. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis. Metabolic Brain Disease. PMID 33057922 DOI: 10.1007/s11011-020-00618-y   
2020 Cerri S, Blandini F. An update on the use of non-ergot dopamine agonists for the treatment of Parkinson's disease. Expert Opinion On Pharmacotherapy. 1-13. PMID 32804544 DOI: 10.1080/14656566.2020.1805432   
2020 Friedman JH. Movement disorders induced by psychiatric drugs that do not block dopamine receptors. Parkinsonism & Related Disorders. 79: 60-64. PMID 32871538 DOI: 10.1016/j.parkreldis.2020.08.031   
2020 Alipour Nosrani E, Tamtaji OR, Alibolandi Z, Sarkar P, Ghazanfari M, Azami Tameh A, Taghizadeh M, Banikazemi Z, Hadavi R, Naderi Taheri M. Neuroprotective effects of probiotics bacteria on animal model of Parkinson's disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study. Journal of Immunoassay & Immunochemistry. 1-15. PMID 33078659 DOI: 10.1080/15321819.2020.1833917   
2020 Huang X, Lewis MM, Van Scoy LJ, De Jesus S, Eslinger PJ, Arnold AC, Miller AJ, Fernandez-Mendoza J, Snyder B, Harrington W, Kong L, Wang X, Sun D, Delnomdedieu M, Duvvuri S, et al. The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study. Journal of Parkinson's Disease. PMID 32986682 DOI: 10.3233/JPD-202188   
2020 Chung SJ, Lee S, Yoo HS, Lee YH, Lee HS, Choi Y, Lee PH, Yun M, Sohn YH. Association of the Non-Motor Burden with Patterns of Striatal Dopamine Loss in de novo Parkinson's Disease. Journal of Parkinson's Disease. PMID 32925098 DOI: 10.3233/JPD-202127   
2020 Pingale T, Gupta GL. Current and emerging therapeutic targets for Parkinson's disease. Metabolic Brain Disease. PMID 33090348 DOI: 10.1007/s11011-020-00636-w   
2020 Vinding MC, Tsitsi P, Waldthaler J, Oostenveld R, Ingvar M, Svenningsson P, Lundqvist D. Reduction of spontaneous cortical beta bursts in Parkinson's disease is linked to symptom severity. Brain Communications. 2: fcaa052. PMID 32954303 DOI: 10.1093/braincomms/fcaa052   
2020 Liu L, Li M, Xu M, Wang Z, Zeng Z, Li Y, Zhang Y, You R, Li CH, Guan YQ. Actively targeted gold nanoparticle composites improve behavior and cognitive impairment in Parkinson's disease mice. Materials Science & Engineering. C, Materials For Biological Applications. 114: 111028. PMID 32994016 DOI: 10.1016/j.msec.2020.111028   
2020 Wi R, Chung YC, Jin BK. Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease. Journal of Immunology Research. 2020: 5093493. PMID 33062722 DOI: 10.1155/2020/5093493   
2020 Tang J, Xu Y, Liu C, Fang Y, Cao S, Zhao C, Huang H, Zou M, Chen Z. PET imaging with [F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data. Nuclear Medicine and Biology. 90: 1-9. PMID 32861175 DOI: 10.1016/j.nucmedbio.2020.08.002   
2020 Li H, Liang S, Yu Y, Wang Y, Cheng Y, Yang H, Tong X. Effect of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) on balance performance in Parkinson's disease. Plos One. 15: e0238936. PMID 32915893 DOI: 10.1371/journal.pone.0238936   
2020 Li C, An H, Wang J, Jiang Z, Zhang T, Huo Q. Comparison of efficacy and safety of complementary and alternative therapies for Parkinson's disease: A Bayesian network meta-analysis protocol. Medicine. 99: e22265. PMID 32957377 DOI: 10.1097/MD.0000000000022265   
2020 Brugnoli A, Pisanò CA, Morari M. Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats. Neurobiology of Disease. 144: 105044. PMID 32798726 DOI: 10.1016/j.nbd.2020.105044   
2020 Li Y, Rong J, Zhong H, Liang M, Zhu C, Chang F, Zhou R. Prenatal Stress Leads to the Altered Maturation of Corticostriatal Synaptic Plasticity and Related Behavioral Impairments Through Epigenetic Modifications of Dopamine D2 Receptor in Mice. Molecular Neurobiology. PMID 32935231 DOI: 10.1007/s12035-020-02127-6